nworeport.me By Julian Conradson
Pfizer is apparently at it again, conveniently hitting another grand slam with another perfectly timed drug release for the latest viral outbreak sweeping the west â Monkeypox.
After hitting it out of the park with their experimental mRNA Covid vaccine â typically what would be considered a once-in-a-lifetime development thatâs cashing the company out to a tune of $1,000 per second â it seems like a long stretch that Pfizer would be involved in the âcureâ for the new outbreak, but hey, they apparently pulled it off.
Either way, here comes a Pfizer affiliate with another healthcare âsolutionâ as monkeypox becomes the new Covid…
